Health & Medicine
-
Senolytics: Clearing Senescent Cells to Combat Age-Related Disease
ROCHESTER, Minnesota, July 8 — For a field that began with a single question about aging cells, senolytic research has come a…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Alzheimer’s in America: 6.9 million patients and $360 billion in care costs in 2024
WASHINGTON, July 8 — The numbers arrive with the cold weight of an epidemic that refuses to recede. By 2024, an estimated…
-
Alzheimer’s antibody drugs slow decline by up to 35%, but side effects and cost limit uptake
TOKYO, July 8 — The story of Eisai, the Japanese pharmaceutical company that brought the Alzheimer’s drug lecanemab to market, is not…
-
Immunization Prevents 3.5 Million to 5 Million Deaths a Year, WHO Says, but Coverage Gaps Persist
GENEVA, July 8 — The World Health Organization estimates that immunization prevents 2-3 million deaths every year from diseases including diphtheria, tetanus,…
-
Alzheimer’s Drug History: From Symptoms to Disease Modification
INDIANAPOLIS, July 8 — The clinical record for Alzheimer’s disease treatments, a field marked by more than a century of frustration, now…
-
Lecanemab and Donanemab: Biology of Amyloid-Targeting Drugs
ISLAMABAD, July 8 — For decades, the sticky clumps of protein that build up in the brains of Alzheimer’s patients have been…
-
Two Antibody Drugs Now Slow Early Alzheimer’s Decline, With Brain-Swelling Risks
WASHINGTON — For the millions of American families touched by Alzheimer’s disease, the past few years have brought something that once felt…
-
Wakefield’s 1998 MMR Fraud Fueled Vaccine Hesitancy
LONDON — The scene outside the Wellcome Collection on Euston Road this morning was quiet, a stark contrast to the storm that…
-
How Jonas Salk’s 1954 Field Trial With 1.8 Million Children Led to the Polio Vaccine
NEW YORK, July 8 — 1.8 million children. That is the figure that matters from the 1954 field trial of Jonas Salk’s…
-
Pasteur’s 1881 Anthrax Vaccine Trial Was a Public Test, but the Vaccine Was Not What He Claimed
PARIS, July 8 — The mechanics of how a 19th-century chemist reshaped modern medicine are worth dissecting, because the story is less…
-
From Dead Salmon to Dementia Questions: The Tire Chemical Under Scrutiny
SAN FRANCISCO, July 7 — A team at the University of California, San Francisco has identified a mechanism by which a common…
-
FDA Approves Breyanzi CAR-T Therapy for Relapsed Chronic Lymphocytic Leukemia
MANILA, July 7 — For families across the region watching loved ones battle blood cancers that keep returning, a new treatment option…
-
Rye pollen compounds’ structures unlocked after decades for cancer research
CHICAGO, July 7 — Nearly 30 years ago, researchers discovered two unusual molecules in rye pollen that appeared to slow tumor growth…
-
Tire chemical linked to new Alzheimer’s risk factor
SAN FRANCISCO — A study published in 2024 in the journal Environmental Health Perspectives has identified a chemical, 6PPD-quinone, as a potential…
-
Computer Study Links Tire Chemical 6PPD-Q to Alzheimer’s Proteins, With Major Caveats
LONDON — A chemical born from the friction between tyre rubber and road asphalt has been identified as a potential risk factor…
-
Tire Pollution: A Growing Environmental Health Concern
WASHINGTON, July 7 — Tires are everywhere. Roughly 1.5 billion of them are produced annually worldwide, and when they wear down, the…
-
Strand Life Sciences secures patent for blood-based cancer detection technology
NEW DELHI, July 7 — A Bengaluru-based life sciences company has secured a patent from the Indian patent office for a platform…
-
Computer Study Links Tyre Chemical 6PPD-Quinone to Genes Tied to Alzheimer’s Disease
WASHINGTON — A chemical found in a tire preservative may be interfering with the inner workings of brain cells, raising early questions…
-
Chemical in Tires Linked to Potential Alzheimer’s Risk
WASHINGTON, July 7 — The chemical that keeps tires from crumbling under the sun may be linked to one of the most…
-
Northwestern Chemists Confirm Structures of Two Rye Pollen Molecules Tied to Tumor Clearance in Animals
MANILA, July 7 — A team of scientists has identified two new molecules from rye pollen that could one day change how…
-
Tire Pollutant 6PPD-Quinone Binds Alzheimer’s-Linked Proteins in Computer Models, Study Finds
SAN FRANCISCO — A new study from the University of California, San Francisco has linked a common tire chemical to an elevated…
-
CAR-T Sales in 2023: Gilead’s Yescarta Led at $1.5 Billion as Kymriah Slipped
ISLAMABAD, July 7 — The global market for CAR-T cell therapy, a personalized cancer treatment that reprograms a patient’s own immune cells…
-
Strand Life Sciences secures patent for early cancer detection blood test
BENGALURU, July 7 — An Indian biotechnology company has secured a patent for a blood test platform designed to catch cancer earlier…
Most read
-
Baby & Beyond Maternity Expo in Kuala Lumpur 2026
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Dynasty Trusts Preserve Wealth for a Century Using GST Exemptions
-
Experimental Drug Combo Doubles One-Year Survival Rates in Pancreatic Cancer Trial
-
Factor XIa Inhibitor Asundexian Cuts Recurrent Stroke Risk Without Raising Major Bleeding
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
-
FDA orders class-wide GLP-1 label update for rare eye disease risk
-
Why Oncology Trials Chase Surrogate Endpoints the FDA Ignores
-
Why Achieve Says Most Americans Feel Their Financial Stability is Slipping Away
-
Locking In High Yields: How Current CD Rates Offer Safe Returns Amid Shifting Economic Outlooks
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
-
India’s NPPA slashes 137 cancer drug prices by up to 96%, saving ₹3,500 crore annually
-
Inside AbbVie’s High-Stakes Neuro Portfolio and Pipeline Strategy
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992